The Chemours Company
CC
$12.79
$0.322.57%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.62% | 1.20% | -1.36% | -4.28% | -2.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.62% | 1.20% | -1.36% | -4.28% | -2.80% |
| Cost of Revenue | 3.13% | 2.49% | 0.83% | -2.20% | -1.01% |
| Gross Profit | -9.80% | -4.20% | -9.74% | -11.87% | -9.58% |
| SG&A Expenses | 8.45% | 13.85% | 2.71% | 7.43% | -10.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.58% | 3.66% | 0.98% | -1.12% | -2.10% |
| Operating Income | -33.33% | -27.63% | -25.53% | -32.15% | -10.17% |
| Income Before Tax | -628.95% | -442.17% | 110.98% | 136.71% | 112.03% |
| Income Tax Expenses | 567.86% | 618.52% | 132.26% | 151.85% | -- |
| Earnings from Continuing Operations | -603.03% | -485.45% | 104.91% | 131.49% | 120.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 50.00% | 50.00% | -- | -- | -- |
| Net Income | -620.31% | -493.52% | 104.88% | 131.22% | 120.25% |
| EBIT | -33.33% | -27.63% | -25.53% | -32.15% | -10.17% |
| EBITDA | -17.63% | -15.05% | -15.85% | -22.68% | -8.21% |
| EPS Basic | -616.54% | -491.03% | 104.90% | 131.26% | 120.30% |
| Normalized Basic EPS | -64.33% | -55.72% | -49.10% | -53.84% | -32.40% |
| EPS Diluted | -657.51% | -507.04% | 103.63% | 129.18% | 118.80% |
| Normalized Diluted EPS | -64.27% | -55.45% | -49.02% | -53.67% | -31.98% |
| Average Basic Shares Outstanding | 0.55% | 0.63% | 0.54% | 0.40% | 0.05% |
| Average Diluted Shares Outstanding | 0.34% | 0.08% | 0.23% | 0.06% | -0.29% |
| Dividend Per Share | -32.50% | -16.25% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -1.13% | -1.21% | 21.36% | 4.18% | 5.94% |